Table 1 Description and origin of HNSCC cell lines including therapy received and survival of patients whose tumors were established in culture.
From: In vitro chemosensitivity of head and neck cancer cell lines
UM-SCC 10A | Larynx carcinoma (T3), biopsy taken during surgical treatment, survival time 22 months |
|---|---|
UM-SCC 10B | Biopsy of metastasis in a cervical lymph node of the primary tumor UM-SCC 10A |
UM-SCC 11B | Larynx carcinoma (T2N2a) after chemo- therapy with CIS and BLM. Biopsy taken during surgery, survival time 14 months |
UM-SCC 14A | Recurrent carcinoma of the mouth (T1N0) after repeated surgical treatment and radio- therapy. Biopsy taken during surgery, survival time 93 months |
UM-SCC 14B | Biopsy of second recurrence of carcinoma UM-SCC 14A before treatment |
UM-SCC 14C | Biopsy of third recurrence of carcinoma UM-SCC 14A after surgery and chemoradiotherapy with 5-FU, VCR and MTX |
UM-SCC 22B | Metastasis in a cervical lymph node of a previously untreated hypopharynx carcinoma (T2N1M0), survival time 10 months |
HLac 79 | Metastasis in a cervical lymph node of a larynx carcinoma |
8029 NA | Recloned subpopulation of HLac 79 (limiting dilution) |
8029 DDP | variant of 8029 NA with experimentally induced CIS resistance |